WIP is a chaperone for Wiskott–Aldrich syndrome protein (WASP)

Wiskott–Aldrich syndrome protein (WASP) is in a complex with WASP-interacting protein (WIP). WASP levels, but not mRNA levels, were severely diminished in T cells from WIP−/− mice and were increased by introduction of WIP in these cells. The WASP binding domain of WIP was shown to protect WASP from degradation by calpain in vitro. Treatment with the proteasome inhibitors MG132 and bortezomib increased WASP levels in T cells from WIP−/− mice and in T and B lymphocytes from two WAS patients with missense mutations (R86H and T45M) that disrupt WIP binding. The calpain inhibitor calpeptin increased WASP levels in activated T and B cells from the WASP patients, but not in primary T cells from the patients or from WIP−/− mice. Despite its ability to increase WASP levels proteasome inhibition did not correct the impaired IL-2 gene expression and low F-actin content in T cells from the R86H WAS patient. These results demonstrate that WIP stabilizes WASP and suggest that it may also be important for its function.

[1]  R. Geha,et al.  WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha. , 2006, International immunology.

[2]  F. Rosen,et al.  Genotype-Proteotype Linkage in the Wiskott-Aldrich Syndrome1 , 2005, The Journal of Immunology.

[3]  Silvia Giliani,et al.  Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. , 2004, Blood.

[4]  S. Gygi,et al.  Toca-1 Mediates Cdc42-Dependent Actin Nucleation by Activating the N-WASP-WIP Complex , 2004, Cell.

[5]  J. Hartwig,et al.  WIP Regulates Signaling via the High Affinity Receptor for Immunoglobulin E in Mast Cells , 2004, The Journal of experimental medicine.

[6]  A. Nienhuis,et al.  Functional correction of T cells derived from patients with the Wiskott–Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein , 2003, Gene Therapy.

[7]  Michael J. Byrne,et al.  Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. , 2002, Molecular cell.

[8]  W. Lim,et al.  Structure of the N-WASP EVH1 Domain-WIP Complex Insight into the Molecular Basis of Wiskott-Aldrich Syndrome , 2002, Cell.

[9]  Shiro Suetsugu,et al.  Sustained activation of N-WASP through phosphorylation is essential for neurite extension. , 2002, Developmental cell.

[10]  P. Aspenström.  The WASP-binding protein WIRE has a role in the regulation of the actin filament system downstream of the platelet-derived growth factor receptor. , 2002, Experimental cell research.

[11]  T. Takenawa,et al.  WICH, a novel verprolin homology domain-containing protein that functions cooperatively with N-WASP in actin-microspike formation. , 2002, Biochemical and biophysical research communications.

[12]  J. Derry,et al.  Flow cytometric determination of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral blood lymphocyte subpopulations. , 2002, Journal of immunological methods.

[13]  J. Hartwig,et al.  WIP deficiency reveals a differential role for WIP and the actin cytoskeleton in T and B cell activation. , 2002, Immunity.

[14]  T. Takenawa,et al.  WASP and N-WASP in human platelets differ in sensitivity to protease calpain. , 2001, Blood.

[15]  M. Kirschner,et al.  CR16 forms a complex with N-WASP in brain and is a novel member of a conserved proline-rich actin-binding protein family , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Gerra L. Bosco,et al.  Wasp recruitment to the T cell:APC contact site occurs independently of Cdc42 activation. , 2001, Immunity.

[17]  J. Hartwig,et al.  WIP regulates N-WASP-mediated actin polymerization and filopodium formation , 2001, Nature Cell Biology.

[18]  S. Kawashima,et al.  Calpain Function in the Modulation of Signal Transduction Molecules , 2001, Biological chemistry.

[19]  R. J. Woods,et al.  Radiation Processing: Current Status and Future Possibilities , 2000 .

[20]  H. Ochs,et al.  Molecular biology of the Wiskott-Aldrich syndrome. , 2000, Reviews in immunogenetics.

[21]  K. Siminovitch,et al.  Antigen Receptor–Induced Activation and Cytoskeletal Rearrangement Are Impaired in Wiskott-Aldrich Syndrome Protein–Deficient Lymphocytes , 1999, The Journal of experimental medicine.

[22]  C. Martínez-A,et al.  Implication of calpain in caspase activation during B cell clonal deletion , 1999, The EMBO journal.

[23]  F. Martinon,et al.  Degradation of ZAP-70 following antigenic stimulation in human T lymphocytes: role of calpain proteolytic pathway. , 1999, Journal of immunology.

[24]  D. Nelson,et al.  Mutations that cause the Wiskott-Aldrich syndrome impair the interaction of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein. , 1999, Journal of immunology.

[25]  C. Saxe,et al.  SCAR, a WASP-related Protein, Isolated as a Suppressor of Receptor Defects in Late Dictyostelium Development , 1998, The Journal of cell biology.

[26]  R. Geha,et al.  The Wiskott-Aldrich Syndrome Protein-interacting Protein (WIP) Binds to the Adaptor Protein Nck* , 1998, The Journal of Biological Chemistry.

[27]  Philip R. Cohen,et al.  Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. , 1998, Immunity.

[28]  J. Hartwig,et al.  WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Gallego,et al.  Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation , 1997 .

[30]  W. Leonard,et al.  Functional cleavage of the common cytokine receptor γ chain (γc) by calpain , 1997 .

[31]  K. Miura,et al.  N‐WASP, a novel actin‐depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2‐dependent manner downstream of tyrosine kinases. , 1996, The EMBO journal.

[32]  T. Roszman,et al.  Proteolytic cleavage of alpha-actinin by calpain in T cells stimulated with anti-CD3 monoclonal antibody. , 1996, Journal of immunology.

[33]  B. Druker,et al.  Crkl is constitutively tyrosine phosphorylated in platelets from chronic myelogenous leukemia patients and inducibly phosphorylated in normal platelets stimulated by thrombopoietin. , 1996, Blood.

[34]  E. Hogan,et al.  Calpain Expression in Lymphoid Cells , 1995, The Journal of Biological Chemistry.

[35]  U. Francke,et al.  Isolation of a novel gene mutated in Wiskott-Aldrich syndrome , 1994, Cell.

[36]  D. Adams,et al.  Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells , 1993, The Journal of experimental medicine.

[37]  T. Sasaki,et al.  Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates. , 1984, The Journal of biological chemistry.